Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.088 AUD | +4.76% | +17.95% | -36.55% |
Apr. 30 | ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8% | MT |
Apr. 30 | Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.55% | 114M | |
+12.85% | 229B | |
+13.88% | 195B | |
+18.39% | 142B | |
+28.78% | 109B | |
+1.67% | 64.85B | |
+18.24% | 54.33B | |
+7.04% | 52.09B | |
+10.83% | 45.15B | |
+5.94% | 37.39B |
- Stock Market
- Equities
- IPD Stock
- News ImpediMed Limited
- Impedimed's Bioimpedance Spectroscopy Platform Gets Boost Following US Cancer Network Guideline Update